Literature DB >> 33387071

Symptom Management in Pancreatic Cancer.

Kristina G Lee1,2, Varun Roy3, Meghan Laszlo1, Katelyn M Atkins4, Katrina J Lin5, Shant Tomassian1, Andrew E Hendifar6.   

Abstract

OPINION STATEMENT: Despite extensive research that has identified new risk factors, genetic mutations, and therapeutic options, pancreatic ductal adenocarcinoma continues to be a leading cause of cancer related death. Patients with pancreatic cancer, along with their clinicians, must balance realistic hope alongside a life-threatening diagnosis. As the search for treatments to reduce the morbidity and mortality continues, symptom management and quality of life remain the focus of our efforts. In addition to side effects of cancer-directed therapy, patients are at risk for malnutrition, pain, and fatigue. These factors are often overlooked in practice, so a multidisciplinary team is critical in optimizing the care of patients.

Entities:  

Keywords:  Ascites; Depression; Multidisciplinary approach; Pancreatic cancer; Portal hypertension; Symptom management; Weight loss

Mesh:

Year:  2021        PMID: 33387071     DOI: 10.1007/s11864-020-00801-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  75 in total

Review 1.  Pain in pancreatic ductal adenocarcinoma: A multidisciplinary, International guideline for optimized management.

Authors:  Asbjørn M Drewes; Claudia M Campbell; Güralp O Ceyhan; Myriam Delhaye; Pramod K Garg; Harry van Goor; Berta Laquente; Bart Morlion; Søren S Olesen; Vikesh K Singh; Per Sjøgren; Eva Szigethy; John A Windsor; Marina G Salvetti; Rupjyoti Talukdar
Journal:  Pancreatology       Date:  2018-04-22       Impact factor: 3.996

2.  Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

Authors:  Davendra P S Sohal; Erin B Kennedy; Alok Khorana; Mehmet S Copur; Christopher H Crane; Ignacio Garrido-Laguna; Smitha Krishnamurthi; Cassadie Moravek; Eileen M O'Reilly; Philip A Philip; Ramesh K Ramanathan; Joseph T Ruggiero; Manish A Shah; Susan Urba; Hope E Uronis; Michelle W Lau; Daniel Laheru
Journal:  J Clin Oncol       Date:  2018-05-23       Impact factor: 44.544

3.  Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Edward P Balaban; Pamela B Mangu; Alok A Khorana; Manish A Shah; Somnath Mukherjee; Christopher H Crane; Milind M Javle; Jennifer R Eads; Peter Allen; Andrew H Ko; Anitra Engebretson; Joseph M Herman; John H Strickler; Al B Benson; Susan Urba; Nelson S Yee
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

4.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

Review 5.  Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments.

Authors:  Andreas I Koulouris; Paul Banim; Andrew R Hart
Journal:  Dig Dis Sci       Date:  2017-02-22       Impact factor: 3.199

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

7.  Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases.

Authors:  Güralp O Ceyhan; Frank Bergmann; Mustafa Kadihasanoglu; Burak Altintas; Ihsan E Demir; Ulf Hinz; Michael W Müller; Thomas Giese; Markus W Büchler; Nathalia A Giese; Helmut Friess
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

8.  The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain.

Authors:  Raquel de Oliveira; Marlene P dos Reis; Wiliam A Prado
Journal:  Pain       Date:  2004-07       Impact factor: 6.961

9.  Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial.

Authors:  Gilbert Y Wong; Darrell R Schroeder; Paul E Carns; Jack L Wilson; David P Martin; Michelle O Kinney; Carlos B Mantilla; David O Warner
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

Review 10.  Pathogenesis and Treatment of Pancreatic Cancer Related Pain.

Authors:  Ines Lohse; Shaun P Brothers
Journal:  Anticancer Res       Date:  2020-04       Impact factor: 2.480

View more
  2 in total

1.  Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review.

Authors:  Milly Buwenge; Alessandra Arcelli; Francesco Cellini; Francesco Deodato; Gabriella Macchia; Savino Cilla; Erika Galietta; Lidia Strigari; Claudio Malizia; Silvia Cammelli; Alessio G Morganti
Journal:  Curr Oncol       Date:  2022-04-11       Impact factor: 3.109

2.  Hypoxia-Related Gene FUT11 Promotes Pancreatic Cancer Progression by Maintaining the Stability of PDK1.

Authors:  Wenpeng Cao; Zhirui Zeng; Runsang Pan; Hao Wu; Xiangyan Zhang; Hui Chen; Yingjie Nie; Zijiang Yu; Shan Lei
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.